Your browser doesn't support javascript.
loading
Racial differences in postpandemic trends in prostate-specific antigen screening.
Qian, Zhiyu; Alexander, Jameshisa; Daniels, Danesha; Abdollah, Firas; Cole, Alexander P; Iyer, Hari S; Trinh, Quoc-Dien.
Afiliación
  • Qian Z; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Alexander J; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Daniels D; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Abdollah F; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Cole AP; Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Iyer HS; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Trinh QD; Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation, Henry Ford Hospital, Detroit, MI, USA.
JNCI Cancer Spectr ; 8(2)2024 Feb 29.
Article en En | MEDLINE | ID: mdl-38546486
ABSTRACT
Our study investigates the trends in prostate cancer screening amid the COVID-19 pandemic, particularly focusing on racial disparities between Black and White men. Utilizing data from the Behavioral Risk Factor Surveillance System from 2018, 2020, and 2022, we analyzed prostate-specific antigen screening rates in men aged 45-75 years. Our findings reveal initial declines in screening rates for both groups during the pandemic, with subsequent recovery; however, the pace of rebound differed statistically significantly between races. Whereas White men showed a notable increase in screening rates postpandemic, Black men's rates recovered more slowly. This disparity underscores the impact of socioeconomic factors, health-care access, and possibly systemic biases affecting health-care delivery. Our study highlights the need for targeted interventions to address these inequalities and ensure equitable access to prostate cancer preventive care in the aftermath of COVID-19.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / COVID-19 Límite: Humans / Male Idioma: En Revista: JNCI Cancer Spectr Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / COVID-19 Límite: Humans / Male Idioma: En Revista: JNCI Cancer Spectr Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos